These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 9294330

  • 1. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y, Yuki N.
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [Abstract] [Full Text] [Related]

  • 2. Ability to remove immunoglobulins and antiganglioside antibodies by double filtration plasmapheresis in Guillain-Barré syndrome: is it equivalent to plasma exchange?
    Tagawa Y, Yuki N, Hirata K.
    Ther Apher; 1997 Nov; 1(4):336-9. PubMed ID: 10225726
    [Abstract] [Full Text] [Related]

  • 3. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
    Okamiya S, Ogino M, Ogino Y, Irie S, Kanazawa N, Saito T, Sakai F.
    Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of anti-glycolipid antibody-associated neuropathy].
    Yuki N.
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1232-4. PubMed ID: 10791085
    [Abstract] [Full Text] [Related]

  • 5. [Plasmapheresis in 2 children with Guillain-Barré syndrome].
    Rotteveel JJ, Mullaart RA, Weemaes CM, van Empelen R.
    Tijdschr Kindergeneeskd; 1983 Apr; 51(2):57-62. PubMed ID: 6879585
    [Abstract] [Full Text] [Related]

  • 6. Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption.
    Tagawa Y, Yuki N, Hirata K.
    J Neurol Sci; 1998 Apr 15; 157(1):90-5. PubMed ID: 9600682
    [Abstract] [Full Text] [Related]

  • 7. [Apheresis therapy in Guillain-Barré syndrome].
    Nagayama H, Katayama Y.
    Nihon Rinsho; 2008 Jun 15; 66(6):1195-9. PubMed ID: 18540370
    [Abstract] [Full Text] [Related]

  • 8. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
    Yamazaki M, Koh CS, Hanyu N, Sakai T, Inoue A, Yanagisawa N.
    Arerugi; 1995 Apr 15; 44(4):498-502. PubMed ID: 7598643
    [Abstract] [Full Text] [Related]

  • 9. [Double filtration and immunoadsorption plasmapheresis in Guillain-Barré syndrome].
    Kuwabara S, Nakajima M, Moroo I, Hirayama K.
    Rinsho Shinkeigaku; 1996 Feb 15; 36(2):289-92. PubMed ID: 8752682
    [Abstract] [Full Text] [Related]

  • 10. Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
    Lyu RK, Chen WH, Hsieh ST.
    Ther Apher; 2002 Apr 15; 6(2):163-6. PubMed ID: 11982959
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T, Nakagawa H, Uchiyama F, Fukuyama J.
    Rinsho Shinkeigaku; 1993 Jun 15; 33(6):660-2. PubMed ID: 8403689
    [Abstract] [Full Text] [Related]

  • 12. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].
    Hidou M, Olivier J, Vivant JF.
    Rev Neurol (Paris); 1992 Jun 15; 148(11):706-8. PubMed ID: 1303562
    [Abstract] [Full Text] [Related]

  • 13. Plasma exchange and i.v.-immunoglobulins: new approaches to the treatment of Guillain-Barre' syndrome.
    Fasanaro AM, Pizza V, Stella L.
    Acta Neurol (Napoli); 1992 Jun 15; 14(4-6):369-80. PubMed ID: 1293980
    [Abstract] [Full Text] [Related]

  • 14. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
    Miyamoto Y, Hamasaki Y, Matsumoto A, Doi K, Noiri E, Nangaku M.
    J Clin Apher; 2018 Oct 15; 33(5):611-615. PubMed ID: 30188580
    [Abstract] [Full Text] [Related]

  • 15. [Double filtration plasmapheresis (DFPP) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
    Kumazawa K, Yuasa N, Mitsuma T, Nagamatsu M, Sobue G.
    Rinsho Shinkeigaku; 1998 Aug 15; 38(8):719-23. PubMed ID: 9916516
    [Abstract] [Full Text] [Related]

  • 16. [The number of plasma exchanges in Guillain-Barré syndrome: evaluation by the removal rate of immunoglobulin G].
    Tagawa Y, Yuki N, Hirata K.
    Rinsho Shinkeigaku; 1998 Aug 15; 38(10-11):951-4. PubMed ID: 10203982
    [Abstract] [Full Text] [Related]

  • 17. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
    Yu X, Ma J, Tian J, Jiang S, Xu P, Han H, Wang L.
    J Clin Rheumatol; 2007 Aug 15; 13(4):193-8. PubMed ID: 17762452
    [Abstract] [Full Text] [Related]

  • 18. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients.
    Otsubo S, Tanabe K, Shinmura H, Ishikawa N, Tokumoto T, Hattori M, Ito K, Nitta K, Akiba T, Nihei H, Toma H.
    Ther Apher Dial; 2004 Aug 15; 8(4):299-304. PubMed ID: 15274681
    [Abstract] [Full Text] [Related]

  • 19. Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan.
    Yamada H, Takamori K.
    Ther Apher Dial; 2008 Oct 15; 12(5):355-9. PubMed ID: 18937717
    [Abstract] [Full Text] [Related]

  • 20. Plasmapheresis in the treatment of four cases of Guillain-Barré syndrome (acute form).
    Zerbi D, Celano I, Forlani G, Garelli S, Mosconi L, Valbonesi M.
    Ital J Neurol Sci; 1981 Dec 15; 2(4):331-6. PubMed ID: 7333823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.